UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

The New England journal of medicine, 1997-07, Vol.337 (3), p.141-147

1997

Link zum Volltext

Verfügbarkeit prüfen

14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T C 2 and CD8 + lymphocytes from patients with scleroderma

Journal of allergy and clinical immunology, 2018-07, Vol.142 (1), p.109-119.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

The Journal of pediatrics, 1997-07, Vol.131 (1), p.55-62

1997

Link zum Volltext

Verfügbarkeit prüfen

Lysosomal Acid α-Glucosidase Consists of Four Different Peptides Processed from a Single Chain Precursor

The Journal of biological chemistry, 2005-02, Vol.280 (8), p.6780-6791

2005

Link zum Volltext

Verfügbarkeit prüfen

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

Arthritis and rheumatism, 2012-09, Vol.64 (9), p.2824-2835

2012

Link zum Volltext

Verfügbarkeit prüfen

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis

Journal of rheumatology, 1996-11, Vol.23 (11), p.1849

1996

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)

Journal of rheumatology, 2008-07, Vol.35 (7), p.1346

2008

Link zum Volltext

Verfügbarkeit prüfen

Decreased incidence of left common iliac vein compression in patients with abdominal aortic aneurysms

Journal of vascular surgery, 2006-09, Vol.44 (3), p.595-600

2006

Link zum Volltext

Verfügbarkeit prüfen

A 2-phase screening process for patients with Wegener's granulomatosis: a pilot study

Journal of rheumatology, 2003-11, Vol.30 (11), p.2420

2003

Link zum Volltext

Verfügbarkeit prüfen

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial

Arthritis and rheumatism, 2002-03, Vol.46 (3), p.614-624

2002

Link zum Volltext

Verfügbarkeit prüfen

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial

Arthritis and rheumatism, 2008-05, Vol.58 (5), p.1299-1309

2008

Link zum Volltext

Verfügbarkeit prüfen

Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis

Journal of rheumatology, 1998-02, Vol.25 (2), p.221

1998

Link zum Volltext

Verfügbarkeit prüfen

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five days after the first infusion

Arthritis and rheumatism, 2002-06, Vol.46 (6), p.1470-1479

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study

Arthritis and rheumatism, 2008-09, Vol.58 (9), p.2882-2891

2008

Link zum Volltext

Verfügbarkeit prüfen

Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis

Journal of rheumatology, 1996-11, Vol.23 (11), p.1845

1996

Link zum Volltext

Verfügbarkeit prüfen

Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial

Arthritis and rheumatism, 2008-08, Vol.58 (8), p.2470-2480

2008

Link zum Volltext

Verfügbarkeit prüfen

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double‐blind, placebo‐controlled study

Arthritis and rheumatism, 2003-02, Vol.48 (2), p.442-454

2003

Link zum Volltext

Verfügbarkeit prüfen

Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis

Arthritis and rheumatism, 1993-03, Vol.36 (3), p.307-318

1993

Link zum Volltext

Verfügbarkeit prüfen

Double‐blind, placebo‐controlled multicenter trial using chimeric monoclonal anti‐cd4 antibody, cm‐t412, in rheumatoid arthritis patients receiving concomitant methotrexate

Arthritis and rheumatism, 1995-11, Vol.38 (11), p.1581-1588

1995

Link zum Volltext

Verfügbarkeit prüfen

Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extension

Arthritis and rheumatism, 1995-09, Vol.38 (9), p.1177-1186

1995

Link zum Volltext

Verfügbarkeit prüfen

Nevus of Ota and intracranial arteriovenous malformation

Neurology, 1979-12, Vol.29 (12), p.1625

1979

Link zum Volltext

Verfügbarkeit prüfen

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus

Arthritis and rheumatism, 2004-09, Vol.50 (9), p.2858-2868

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T C 2 and CD8 + lymphocytes from patients with scleroderma

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

Lysosomal Acid α-Glucosidase Consists of Four Different Peptides Processed from a Single Chain Precursor

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)

Decreased incidence of left common iliac vein compression in patients with abdominal aortic aneurysms

A 2-phase screening process for patients with Wegener's granulomatosis: a pilot study

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial

Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five days after the first infusion

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study

Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis

Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double‐blind, placebo‐controlled study

Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis

Double‐blind, placebo‐controlled multicenter trial using chimeric monoclonal anti‐cd4 antibody, cm‐t412, in rheumatoid arthritis patients receiving concomitant methotrexate

Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extension

Nevus of Ota and intracranial arteriovenous malformation

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus

Aktive Filter

Suchergebnisse filtern